Posters

Functional outcomes of the new Precizon Presbyopic NVA multifocal intraocular lens

Poster Details

First Author: M.Holzer GERMANY

Co Author(s):    R. Ruiz Mesa   M. Royo Sans   J. Alió   J. Mendicute del Barrio   F. Ribeiro   T. Kim     

Abstract Details

Purpose:

To evaluate the ability of the multisegmental Precizon Presbyopic NVA Multifocal Intraocular Lens (MIOL; Ophtec, Groningen, The Netherlands) to provide near, intermediate and distance vision in patients undergoing cataract extraction / clear lens extraction (CLE) in a multicenter clinical trial.

Setting:

Multicenter study

Methods:

Prospective, open label, single-arm, multicenter clinical trial. The main outcome parameters were LogMAR corrected/uncorrected visual acuity scores at distance (uncorrected distance visual acuity, UDVA 4 m), intermediate (uncorrected intermediate visual acuity, UIVA 80 cm) and near (uncorrected near visual acuity, UNVA 40 cm), manifest refraction spherical equivalent (MRSE) and defocus curve. Lenses were available in powers ranging from +10.0 D to +30.0 D in 0.5 D increments, with add-on power of +2.75 D.

Results:

55 patients were enrolled in the study and underwent bilateral uneventful MIOL implantation. Interim results at 3 months in 21 patients: Mean uncorrected bilateral VA scores were UDVA 0.01 ± 0.07, UIVA 0.16 ± 0.12, and UNVA 0.22 ± 0.11. Distance corrected VA scores were CDVA -0.02 ± 0.05 and DCNVA 0.22 ± 0.10. CNVA was 0.07 ± 0.08. The mean spherical equivalent was 0.16 ± 0.49 D. The mean sphere was 0.33 ± 0.56 D and the mean refractive cylinder was -0.35 ± 0.45 D. The defocus curve shows good functional VA scores at far, intermediate and near distance.

Conclusions:

Bilateral Precizon Presbyopic NVA MIOL implantation effectively provides presbyopic patients with satisfying uncorrected near, intermediate and distance visual acuity.

Financial Disclosure:

... research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented